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Abstract
Background: Clear, transparent and sufficiently detailed abstracts of randomized trials (RCTs), published in journal articles
are important because readers will often base their initial assessment of a trial on such information. However, little is known
about the quality of reporting in abstracts of RCTs published in medical journals in China.
Methods: We identified RCTs abstracts from 5 five leading Chinese medical journals published between 1998 and 2007 and
indexed in MEDLINE. We assessed the quality of reporting of these abstracts based on the Consolidated Standards of
Reporting Trials (CONSORT) abstract checklist. We also sought to identify whether any differences exist in reporting
between the Chinese and English language version of the same abstract.
Results: We identified 332 RCT abstracts eligible for examination. Overall, the abstracts we examined reported 0–8 items as
designated in the CONSORT checklist. On average, three items were reported per abstract. Details of the interventions (288/
332; 87%), the number of participants randomized (216/332; 65%) and study objectives (109/332; 33%) were the top three
items reported. Only two RCT abstracts reported details of trial registration, no abstracts reported the method of allocation
concealment and only one mentioned specifically who was blinded. In terms of the proportion of RCT abstracts fulfilling a
criterion, the absolute difference (percentage points) between the Chinese and English abstracts was 10% (ranging from 0
to 25%) on average, per item.
Conclusions: The quality of reporting in abstracts of RCTs published in Chinese medical journals needs to be improved. We
hope that the introduction and endorsement of the CONSORT for Abstracts guidelines by journals reporting RCTs will lead
to improvements in the quality of reporting.
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Introduction
There are more than 1200 biomedical journals in China [1],
which publish thousands of randomized controlled trials (RCTs)
each year. Clear, transparent, and sufficiently detailed abstracts of
RCTs are more important particularly in China and other
developing countries where researchers and health professionals
often use an abstract to decide whether to seek more information
about a trial; or may have access to the abstracts only [2]. Previous
studies have attempted to assess the quality of reporting in
abstracts of clinical studies [3] or to assess the quality of reporting
in abstracts of RCTs published in English language journals [4].
The aim of our study is to assess the quality of reporting in
abstracts of RCTs published in five leading Chinese medical
journals using the recent CONSORT (Consolidated Standards of
Reporting Trials) checklist for reporting abstracts of RCTs.
Materials and Methods
1. Selection of journals and sample of abstracts of RCTs
We selected five leading Chinese medical journals indexed in
MEDLINE from 1998 to 2007 with top ranking impact factor (IF)
in each field based on the ‘‘2007 data for Sci-tech Journal Citation
Reports of China’’(Table 1) and with both English and Chinese
abstracts: the National Medical Journal of China, Chinese Journal
of Internal Medicine, Chinese Journal of Obstetrics and
Gynecology, Chinese Journal of Pediatrics, and the Chinese
Journal of Surgery.
The CBM (Chinese Biomedical Database) disk database was
searched using an extended version of the Cochrane Highly
Sensitive Search Strategy [5] (Table 2) to identify RCTs (searched
April, 2008) for Chinese abstracts in each of the five leading
journals. Based on the citation of each RCT, we hand searched
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all publications reporting RCTs,which was defined as a trial where
the allocation of participants to interventions was described by the
words random, randomly, randomized, or randomization in all
disease areas and all types of interventions, dealing with patients or
volunteers.
2. Evaluation Method
We assessed the quality of reporting in abstracts of RCTs based
on the CONSORT for Abstracts checklist [6]. Refined items
from the CONSORT for Abstracts are presented in the Table 3.
We assessed each item as ‘‘reported’’ or ‘‘not reported’’ according
to whether the author reported all the contents listed in the
refined items or not. We checked for any differences in reporting
between the Chinese and English language version of the same
abstract.
We determined the number and proportion (%) of RCT
abstracts that reported each of the CONSORT for Abstracts
checklist items. Four assessors (YL Chen, CL Ai, L Wang and YR
Duan) independently rated each RCT abstract and inter-rater
agreement for each checklist item was determined using the
Kappa statistic. Overall, this produced good agreement between
the reviewers (0.7). Discrepancies were resolved by consensus and
or discussed. Data analysis was carried out using Excel 2003,
Epidata 3.02 and Stata version 9.0.
Results
1. Quality of reporting in Chinese abstracts
We identified 692 abstracts of RCTs during our initial search
and subsequently determined that 332 pairs were eligible for
analysis based on our criteria of findings being reported both
Chinese and English (Figure 1). We have presented the results of
our findings in Table 3. Overall only 10% (34/332) of the abstracts
could be identified as an RCT based on the title. No abstracts
mentioned the method of allocation concealment and, while 49
(15%) RCT abstracts reported on blinding, only one indentified
who was blinded. Although 65 (20%) of the abstracts mentioned
adverse events or side effects, less than 10% reported specific
symptoms (n=20) or rates (n=26). Lastly, 246 (75%) abstracts did
not report their sources of funding.
2. Comparison the quality of reporting between the
Chinese with English abstracts
The results of the English language version of the same RCT
abstracts are also presented in Table 3. In terms of the proportion of
RCT abstracts fulfilling a criterion, the absolute difference
(percentage points) between the Chinese and English abstracts was
10% (ranging from 0 to 25%) on average, per item. Some items such
as details of the primary outcome, were only reported in the English
version of the abstract. Some items were complementary between the
Chinese and English abstracts, for example, some Chinese abstracts
only reported the ‘‘numbers randomized’’ while their corresponding
English abstracts only reported the ‘‘numbers analyzed’’.
Discussion
1. General quality of reporting in abstracts and its
possible reasons
Our study indicates that the quality of reporting in abstracts of
RCTs published in these five leading Chinese medical journals is
insufficient. Overall, the average number of reported items in each
RCT abstract, based on the CONSORT for Abstracts checklist,
was three. None of the abstracts adequately reported the key
features of the trial design, including the method of generating the
allocation sequence, concealment of the allocation, or the
estimated effect size and its precision for the primary outcome.
Less than half of the RCT abstracts reported the study as
randomized in the title, the number of participants analysed,
details of harms, trial registration and source of funding.
Berwanger and colleagues [7] evaluated the quality of reporting
in 227 abstracts describing RCTs published in the New England
Journal of Medicine, JAMA, the BMJ and the Lancet in 2006. In
their paper, the authors identified that details regarding method-
ological quality were also poorly reported as only one RCT
Table 1. Number of abstracts identified and included from five Chinese medical journals.
Name of journal Impact factor Total citations Number of RCTs Percent (%)
Chinese Journal of Pediatrics 1.347 2909 33 9.9%
Chinese Journal of Obstetrics and Gynecology 1.121 2719 50 15.1%
National Medical Journal of China 1.091 3792 121 36.5%
Chinese Journal of Internal Medicine 0.903 2409 68 20.5%
Chinese Journal of Surgery 0.963 3222 60 18%
Total 332 100%
Data of impact factor and total citations are from the China Journal Citation Reports (CJCR) in 2007.
doi:10.1371/journal.pone.0011926.t001
Table 2. Search strategy to identify RCTs in five leading
Chinese medical journals.
1 random$
2 randomized controlled trial/
3 randomized controlled trial$.pt.
4 double blind
5 double blind method/
6 single blind





12 10 not 11)
doi:10.1371/journal.pone.0011926.t002
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clearly specified who was blinded; 51 (23%) described intention-to-
treat analysis; and 32 (14%) outlined losses to follow-up.
In the mid-1990s, Anrong [8] and Bili [9] reported that the quality
of abstracts in Chinese medical journals was poor. They suggested
that poor abstract reporting may indicate suboptimal study design,
inadequate reporting, or both. Previous work has shown that
abstracts frequently under report key features of study design [10–
11] and omit important results. It is suggested that the poor quality of
reporting of Chinese abstracts may also be an indication of poor
reporting in full-text RCTs in China [12–18]. When an item isn’t
reported in the full publication, it is likely to also be missing from the
abstract. A lack of detailed requirement for abstracts in a journal’s
‘Instruction for Authors’is alsoa potential problem.Although most of
the journals included in our study have adopted structured abstracts,
thestructured format alone isnotsufficient toguide authorsregarding
their content. Thus, some of the most salient information might be
missedifnodetailedinstructionsforeachheadingaregiven.Finally,a
lack of sufficient knowledge of research methodology might also
attribute to the poor quality of reporting.
Abstracts should contain the most important information and
accurate study results relevant to clinical practice. While we did
find that most abstracts reported the purported ‘‘study benefits,’’
we also observed that the primary outcome, the estimated effect
size, and the precision and harms of the study were rarely
reported. Cumulatively, this lack of information hampers readers
in making clinical decisions [19–20] and presents clinicians many
difficulties when trying to evaluate the benefits and harms of any
intervention. Unfortunately, only two RCT abstracts reported
details of trial registration.
While, not included in our study, the Chinese Journal of
Evidence-Based Medicine recently introduced the CONSORT for
Table 3. Adapted CONSORT for Abstracts checklist items reported in the 332 journal abstracts of RCTs.







Title Identification of the study as randomized 34 (10%) 47 (14%)
Authors* Contact details for the corresponding author - -
Trial design Description of the trial design 19 (6%) 10 (3%)
Methods
Participants Eligibility criteria for participants and the
settings where the data were collected
9 (3%) 7 (2%)
Eligibility criteria for participants 148(45%) 120 (36%)
Eligibility criteria for settings 15(5%) 13(4%)
Interventions Interventions intended for each group 288 (87%) 310 (93%)
Objective Specific objective or hypothesis 109 (33%) 103 (31%)
Outcome Clearly defined primary outcome for this report 0 0 5 (2%)
Randomization How participants were allocated to interventions 0 0
Description of the method for
assigning participants
10(3%) 1 (0%)
Description of allocation concealment 0 0
Blinding (masking) Whether or not participants, care givers, and
those assessing the outcomes were blinded
to group assignment
00
Description of whether or
not using blinding
49 (15%) 48 (14.%)
Description of who were blinded 0 1 (0%)
Results
Numbers randomized Number of participants randomized to each group 216 (65%) 214 (65%)
Recruitment* Trial status - - -
Numbers analyzed Number of participants analyzed in each group 50 (15%) 42 (13%)
Outcome For the primary outcome, a result for each group
and the estimated effect size and its precision
00
Result for each group 135 (41%) 159(48%)
Estimated effect size of a
result for each group
9 (3%) 4 (1%)
Precision of the estimate 6 (2%) 6 (2%)
Harms Important adverse events or side effects 30 (9%) 33 (10%)
Conclusions General interpretation of the results 22 (7%) 15 (5%)
Trial registration Registration number and name of trial register 2 (1%) 2 (1%)
Funding Source of funding 86 (26%) 86 (26%)
*Authors and Recruitment are most specific to conference abstracts, and were not included.
doi:10.1371/journal.pone.0011926.t003
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application of the CONSORT Statement has demonstrated
benefits in improving the quality of reporting in abstracts [22–24],
and we hope that it will do the same with the introduction of
CONSORT for Abstracts. We very much hope that the five
journals included in our study will also consider including such
guideline to their ‘Instructions for Authors’.
2. Limitations
This study has several limitations, firstly, we did not take a random
sample of all RCT abstracts published in Chinese medical journals
and therefore our findings may not reflect all abstracts of RCTs
published in China or in other countries. Secondly, we did not
compare abstracts with their corresponding full articles, However,
previous studies have shown that the quality of reporting of the full-
text is also poor in the same medical journals [12–18]. We further
wish to point out that the WHO International Clinical Trial Register
Platform only approved The Chinese Clinical Trial Register
(ChiCTR) in 2007. Thus, it may well be that many researchers do
not know the importance of prospective trial registration [25]. While
not included in our current study, the Chinese Journal of Evidence-
Based Medicine recently introduced the CONSORT for Abstracts
guidelines into its ‘Instructions for Authors’ [21]. This adoption has
improved the quality of reporting in other journals [22–24] and it is
our sincere hope that the five journals included in our study, as well as
other Chinese journals, adopt the CONSORT statement for
Abstracts into their ‘Instructions for Authors.’ We believe that this
adoption will markedly improve both the interpretation and practice
of medicine in China in the future.
Conclusions
In summary, the quality of reporting in abstracts of RCTs
published in these five leading Chinese medical journals requires
substantial improvement to meet the recommendations set out in
CONSORT for Abstracts guidelines. With the publication of
CONSORT for Abstracts checklist, we suggest that Chinese
medical journals should adopt these recommendations and do
more to ensure that authors apply to meet internationally agreed
standards, thereby allowing the conduct of their studies to be
monitored and improved.
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